Acadian Asset Management’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $327K | Buy |
107,303
+66,853
| +165% | +$172K | ﹤0.01% | 1544 |
|
|
2026
Q1 | $112K | Buy |
+40,450
| New | +$137K | ﹤0.01% | 1719 |
|
|
2025
Q4 | – | Sell |
-43,109
| Closed | -$158K | – | 2014 |
|
|
2025
Q3 | $158K | Buy |
43,109
+24,553
| +132% | +$62.1K | ﹤0.01% | 1432 |
|
|
2025
Q2 | $34K | Sell |
18,556
-71,950
| -79% | -$125K | ﹤0.01% | 1527 |
|
|
2025
Q1 | $141K | Sell |
90,506
-94,971
| -51% | -$167K | ﹤0.01% | 1304 |
|
|
2024
Q4 | $375K | Sell |
185,477
-297,118
| -62% | -$538K | ﹤0.01% | 1135 |
|
|
2024
Q3 | $696K | Buy |
482,595
+205,087
| +74% | +$391K | ﹤0.01% | 1004 |
|
|
2024
Q2 | $473K | Sell |
277,508
-14,550
| -5% | -$26.4K | ﹤0.01% | 1213 |
|
|
2024
Q1 | $582K | Buy |
292,058
+161,870
| +124% | +$322K | ﹤0.01% | 972 |
|
|
2023
Q4 | $390K | Buy |
130,188
+58,486
| +82% | +$155K | ﹤0.01% | 1088 |
|
|
2023
Q3 | $311K | Hold |
71,702
| – | – | ﹤0.01% | 1108 |
|
|
2023
Q2 | $590K | Buy |
71,702
+3,553
| +5% | +$35.1K | ﹤0.01% | 1012 |
|
|
2023
Q1 | $837K | Buy |
68,149
+17,578
| +35% | +$209K | ﹤0.01% | 920 |
|
|
2022
Q4 | $495K | Hold |
50,571
| – | – | ﹤0.01% | 1033 |
|
|
2022
Q3 | $650K | Buy |
50,571
+5,200
| +11% | +$77.9K | ﹤0.01% | 923 |
|
|
2022
Q2 | $571K | Buy |
45,371
+17,058
| +60% | +$253K | ﹤0.01% | 935 |
|
|
2022
Q1 | $575K | Buy |
28,313
+17,790
| +169% | +$487K | ﹤0.01% | 955 |
|
|
2021
Q4 | $394K | Buy |
+10,523
| New | +$469K | ﹤0.01% | 1066 |
|
|
2021
Q3 | – | Sell |
-5,166
| Closed | -$277K | – | 1797 |
|
|
2021
Q2 | $277K | Sell |
5,166
-28,063
| -84% | -$1.69M | ﹤0.01% | 1340 |
|
|
2021
Q1 | $1.76M | Sell |
33,229
-13,743
| -29% | -$775K | 0.01% | 777 |
|
|
2020
Q4 | $2.23M | Buy |
46,972
+20
| +0% | +$866 | 0.01% | 727 |
|
|
2020
Q3 | $2.85M | Sell |
46,952
-1,102
| -2% | -$56.1K | 0.01% | 573 |
|
|
2020
Q2 | $1.93M | Buy |
48,054
+18,777
| +64% | +$697K | 0.01% | 750 |
|
|
2020
Q1 | $830K | Buy |
29,277
+12,386
| +73% | +$411K | ﹤0.01% | 847 |
|
|
2019
Q4 | $651K | Hold |
16,891
| – | – | ﹤0.01% | 1008 |
|
|
2019
Q3 | $357K | Buy |
16,891
+2,252
| +15% | +$53K | ﹤0.01% | 1174 |
|
|
2019
Q2 | $329K | Buy |
14,639
+4,409
| +43% | +$113K | ﹤0.01% | 1114 |
|
|
2019
Q1 | $273K | Sell |
10,230
-468
| -4% | -$12.3K | ﹤0.01% | 1273 |
|
|
2018
Q4 | $138K | Hold |
10,698
| – | – | ﹤0.01% | 1197 |
|
|
2018
Q3 | $257K | Buy |
10,698
+410
| +4% | +$13.1K | ﹤0.01% | 1032 |
|
|
2018
Q2 | $460K | Buy |
10,288
+6,940
| +207% | +$391K | ﹤0.01% | 911 |
|
|
2018
Q1 | $228K | Buy |
+3,348
| New | +$212K | ﹤0.01% | 1031 |
|
Other funds holding FBIO
VCM
GCP
SAM
VFT
HWM
KAS
Acadian Asset Management's FBIO Position: Q2 2026 in Review
Acadian Asset Management increased its Fortress Biotech (FBIO) stake by 165% in Q2 2026, buying an estimated $172K and bringing the position to 107,303 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1544.
Acadian Asset Management first reported a position in FBIO in Q1 2018 and has held it in 32 quarters since. The position peaked at $2.85M in Q3 2020. 38 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.
- Acadian Asset Management held 107,303 shares of Fortress Biotech worth $327K as of Q2 2026.
- Acadian Asset Management bought 66,853 Fortress Biotech shares in Q2 2026, an estimated $172K.
- Fortress Biotech made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1544 holding.
- Acadian Asset Management first reported a position in Fortress Biotech in Q1 2018 and has held it in 32 quarters since.
- Acadian Asset Management's Fortress Biotech position peaked at $2.85M in Q3 2020.
- 38 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.